Anti-RYR2 antibody
产品特性
| Product Cat#: | AB-06-3942 |
| Product type: | Primary antibody |
| Antigen: | RYR2 |
| Immunogen: | Synthetic peptide within human RYR2 aa 1450-1550 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:200-1:2000); Immunohistochemistry (1:50-1:200); Flow Cytometry (1:50-1:100); Immunocytochemistry (1:50-1:200) |
| Reactivity: | Human, Mouse, Rat |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 0.5% BSA, 50% Glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Peptide affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | Arrhythmogenic right ventricular dysplasia 2 antibody |
| ARVC2 antibody | |
| ARVD2 antibody | |
| Brain ryanodine receptor calcium release channel antibody | |
| Brain type ryanodine receptor antibody | |
| Cardiac muscle ryanodine receptor calcium release channel antibody | |
| Cardiac muscle type ryanodine receptor antibody | |
| CCO antibody | |
| Central core disease of muscle antibody | |
| HBRR antibody | |
| HRYR 2 antibody | |
| HRYR2 antibody | |
| MHS antibody | |
| MHS1 antibody | |
| Ryanodine receptor 1 (skeletal) antibody | |
| Ryanodine receptor 1 antibody | |
| Ryanodine receptor 2 (cardiac) antibody | |
| Ryanodine receptor 2 antibody | |
| Ryanodine receptor 3 antibody | |
| Ryanodine receptor type1 antibody | |
| RYDR antibody | |
| RYR 1 antibody | |
| RYR 2 antibody | |
| RYR 3 antibody | |
| RYR antibody | |
| RYR-1 antibody | |
| RyR1 antibody | |
| RYR1_HUMAN antibody | |
| RYR2 antibody | |
| RYR3 antibody | |
| Sarcoplasmic reticulum calcium release channel antibody | |
| Skeletal muscle calcium release channel antibody | |
| Skeletal muscle ryanodine receptor antibody | |
| Skeletal muscle type ryanodine receptor antibody | |
| Skeletal muscle-type ryanodine receptor antibody | |
| SKRR antibody | |
| Type 1 like ryanodine receptor antibody | |
| Type 1 ryanodine receptor antibody | |
| VTSIP antibody |
展开
靶标信息
Calcium channel that mediates the release of Ca2+ from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca2+ levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.
产品来源
洱畔科技实验室
